On 4/17/19 KCI Holdings filed for a $100 million IPO. KCI is a leading medical technology company focused on advanced wound care and specialty surgical applications. The initial filing did not specify the number of shares to be offered or the symbol the company intends to trade under.
KCI introduced its ground breaking negative pressure wound therapy (NPWT) over 20 years ago. For the year ended December 31, 2018, its NPWT product line generated $1.152 billion of revenue, representing 78.5% of our total revenue and 4.5% growth compared to 2017. The company also has offerings in the specialty surgical market and the advanced wound dressings market.